Thus, in MCL primary cells, dual PI3K/mTOR inhibition is the best strategy to efficiently block PI3K-mediated signaling and to induce major apoptosis, even in the presence of stroma. The gene discussed is PIK3CA; the disease is mantle cell lymphoma.